Literature DB >> 30496990

Norharmane as a potential chemical entity for development of anticancer drugs.

Chita Ranjan Sahoo1, Sudhir Kumar Paidesetty2, Rabindra Nath Padhy3.   

Abstract

Cancer is a leading cause of death generally, and to overcome this problem the introduction of a new drug developing is a continuous endeavour. An alkaloid, norharmane and its derivatives, which have anticancer activities, widely distributed in several living and synthetic chemical sources. Herewith, the suggested mechanisms of organic reactions and synthetic approaches of norharmane available so far were considered. Active sites of norharmane nucleus positions, C-1, C-3, and N-9, were used for developing new molecules and based on structure activity relationship (SAR), those have been seen with anticancer activities. This review summarizes on chemistry of synthetic strategies of norharmane derivatives, which may provide a framework to design a novel anticancer drug, in future.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  9H-pyrido[3,4-b]indole; Chemical synthesis; Cytotoxicity; SAR

Mesh:

Substances:

Year:  2018        PMID: 30496990     DOI: 10.1016/j.ejmech.2018.11.024

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

Review 1.  Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update.

Authors:  Swati Sucharita Mohanty; Chita Ranjan Sahoo; Rabindra Nath Padhy
Journal:  Genes Dis       Date:  2020-12-17

Review 2.  β-Carboline-based molecular hybrids as anticancer agents: a brief sketch.

Authors:  Jay Prakash Soni; Yogesh Yeole; Nagula Shankaraiah
Journal:  RSC Med Chem       Date:  2021-03-24

3.  Biogenic silver nanoparticle synthesis with cyanobacterium Chroococcus minutus isolated from Baliharachandi sea-mouth, Odisha, and in vitro antibacterial activity.

Authors:  Chita Ranjan Sahoo; Subhashree Maharana; Chinmayee Priyadarshini Mandhata; Ajit Kumar Bishoyi; Sudhir Kumar Paidesetty; Rabindra Nath Padhy
Journal:  Saudi J Biol Sci       Date:  2020-03-19       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.